TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
53
|
59
|
104 |
| Financial expenses |
0
|
4
|
0 |
| Earnings before taxes |
6
|
5
|
37 |
| EBITDA |
0
|
9
|
10 |
| Total assets |
276
|
275
|
343 |
| Current assets |
35
|
25
|
32 |
| Current liabilities |
24
|
15
|
29 |
| Equity capital |
240
|
246
|
293 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
87.0%
|
89.5%
|
85.4% |
| Turnover per employee |
53
|
59
|
104 |
| Profit as a percentage of turnover |
11.3%
|
8.5%
|
35.6% |
| Return on assets (ROA) |
2.2%
|
3.3%
|
10.8% |
| Current ratio |
145.8%
|
166.7%
|
110.3% |
| Return on equity (ROE) |
2.5%
|
2.0%
|
12.6% |
| Change turnover |
-8
|
-36
|
3 |
| Change turnover % |
-12%
|
-38%
|
3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.